2023 World Conference on Lung Cancer (Posters)-EP11.03. Patient-Reported Fatigue in Lung Cancer Patients Undergoing Immunotherapy: A Real-Life Study

EP11.03. Patient-Reported Fatigue in Lung Cancer Patients Undergoing Immunotherapy: A Real-Life Study - PDF(Slides)

Pdf Summary

A real-life study was conducted to assess the correlation between patient-reported fatigue and the clinical team's assessment in lung cancer patients undergoing immunotherapy. The study collected data from 31 patients over an 8-month period, using a questionnaire called Brief Fatigue Inventory (BFI) before each treatment cycle. The results showed that fatigue was consistently underreported by the physician during clinical consultations, with a 75% underreporting rate. The BFI questionnaire, on the other hand, was able to identify and stratify different degrees of fatigue severity. The study concludes that the BFI is a sensitive tool for detecting fatigue that is not reported in consultations. It also suggests that further studies with larger sample sizes are needed to confirm these findings. The study highlights the prevalence of fatigue as a common adverse effect in lung cancer patients undergoing immunotherapy and the importance of accurately assessing and addressing this symptom.

Asset Subtitle

Mariana Picado

Meta Tag

Speaker Mariana Picado

Topic Metastatic NSCLC: Immunotherapy - Retrospective

Keywords

real-life study

correlation

patient-reported fatigue

clinical team's assessment

lung cancer patients

immunotherapy

Brief Fatigue Inventory

underreported fatigue

physician underreporting

fatigue severity